StockData
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$7.14−0.01 (-0.14%)

Close on Nov 18, 2026Market cap $740.45MP/E –Yield –

Aura Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Aura Biosciences

Aura Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Aura Biosciences figures

See a number that looks wrong?